1. Home
  2. CAPR vs BCML Comparison

CAPR vs BCML Comparison

Compare CAPR & BCML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Capricor Therapeutics Inc.

CAPR

Capricor Therapeutics Inc.

HOLD

Current Price

$28.56

Market Cap

324.6M

Sector

Health Care

ML Signal

HOLD

Logo BayCom Corp

BCML

BayCom Corp

N/A

Current Price

$29.59

Market Cap

303.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
CAPR
BCML
Founded
2005
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
324.6M
303.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CAPR
BCML
Price
$28.56
$29.59
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
1
Target Price
$36.71
$32.00
AVG Volume (30 Days)
5.9M
15.2K
Earning Date
11-10-2025
01-22-2026
Dividend Yield
N/A
3.39%
EPS Growth
N/A
N/A
EPS
N/A
2.10
Revenue
$11,130,509.00
$94,896,000.00
Revenue This Year
N/A
$0.51
Revenue Next Year
$7,736.03
$10.33
P/E Ratio
N/A
$14.04
Revenue Growth
N/A
N/A
52 Week Low
$4.30
$22.22
52 Week High
$40.37
$30.96

Technical Indicators

Market Signals
Indicator
CAPR
BCML
Relative Strength Index (RSI) 81.16 60.39
Support Level $4.30 $28.84
Resistance Level $40.37 $30.06
Average True Range (ATR) 2.94 0.74
MACD 2.74 0.12
Stochastic Oscillator 67.59 82.09

Price Performance

Historical Comparison
CAPR
BCML

About CAPR Capricor Therapeutics Inc.

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.

About BCML BayCom Corp

BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services.

Share on Social Networks: